Lowest Price Guaranteed From USD 4,799
The global in vitro diagnostics market refers to the market for medical devices and laboratory procedures used to analyze human specimens, such as blood, urine, and tissue, to diagnose diseases, monitor treatment, and assess health status.
In vitro diagnostics are tests conducted on samples such as blood or tissue taken from the human body. These tests can detect diseases, conditions, and infections, and are used to monitor a person’s overall health to help cure, treat, or prevent diseases. In vitro diagnostics can include next-generation sequencing tests, which scan a person’s DNA to detect genomic variations. They are performed in laboratories, health care facilities, or even at home, and can be used to diagnose a wide range of conditions, from traditional laboratory-based tests to point-of-care tests. Over 40,000 products are available for in vitro diagnostic testing, covering a wide range of conditions, including pregnancy tests, COVID-19 tests, and HIV tests. The World Health Organization maintains a network of partnerships dedicated to the rapid diagnosis and containment of potential cases of re-emerging diseases and develops the WHO Model List of Essential in vitro Diagnostics (EDL), a list of recommended tests for point of care in the community and for laboratory use.
The global in vitro diagnostics market is driven by several factors, including the growing demand for point-of-care devices, rapid diagnostic testing, and the increasing prevalence of various diseases. The market is also influenced by factors such as the rising incidence of chronic diseases, a rapidly growing geriatric population, high healthcare expenditure, and supportive government funding. Technological advancements, patient-centric care, and preventive healthcare are also playing a crucial role in the growth of the in vitro diagnostics market.
The in vitro diagnostics market is expected to grow owing to the increasing demand for point-of-care devices and rapid diagnostic testing, as well as the rising prevalence of chronic diseases. However, an unfavorable reimbursement scenario is expected to restrain the growth of this market during the forecast period. Additionally, the high cost of many diagnostic platforms and the sensitivity of the diagnostic market to changes in the macroeconomic cycle are also factors that could limit market growth. Despite these restraints, recent advances in cardiac diagnostic testing, a segment of the in vitro diagnostics market, promise faster results and better accuracy at reduced cost to patients and caregivers.
Major players in the in vitro diagnostics market are expected to find growth opportunities in developing economies such as India, China, South Korea, Brazil, Mexico, Turkey, Russia, and South Africa. The Asia Pacific region, in particular, has emerged as a business-friendly hub due to its relatively less-stringent regulations and data requirements. China is currently one of the largest investors in R&D, and many players are shifting their focus to emerging markets as markets in the US and Europe are maturing.
The in vitro diagnostics market forecast on the basis of products (instruments, reagents and other products). On the basis of technology (immunoassay, hematology, clinical chemistry, molecular diagnostics, coagulation microbiology and other technologies). On the basis of application (infectious disease, diabetes, oncology, cardiology, nephrology, autoimmune disease, drug testing and other applications). On the basis of end user (hospitals, laboratories and other end users). By geographical regions, the market is analyzed across North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America.
Based on applications, the in vitro diagnostics market size and in vitro diagnostics market trends are analyzed across infectious disease, diabetes, oncology, cardiology, nephrology, autoimmune disease, drug testing and other applications. The segment of infectious diseases is expected to remain dominant throughout the forecast period owing to the surge in infectious diseases such as HIV and hepatitis that require diagnostic tests. However, the cancer segment is expected to register the highest compound annual growth rate during the forecast period given to the increase in cancer incidence, advances in biomarker discovery, and the expanding range of diagnostic technologies.
Based on region, the in vitro diagnostics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is expected to maintain its dominance in the market attributing to various factors including favorable government regulations, a well-established diagnostic infrastructure, and the adoption of technologically advanced diagnostic techniques. The US is expected to occupy the majority of the market share in North America, driven by factors such as the growing prevalence of early disease diagnosis, increasing incidences of infectious and chronic diseases, and the adoption of point-of-care testing devices for accurate and timely results. Additionally, Europe is expected to become the second most dominant region in terms of market share owing to various factors such as rising healthcare expenditure, well-established infrastructure, and a large pool of patients suffering from infectious diseases and cancer. Furthermore, The Asia Pacific market is projected to experience the highest CAGR during the forecast period, particularly in developing countries such as India, South Korea, Australia, and China. The market growth in the Asia Pacific region is expected to be driven by improving approval and reimbursement policies, as well as the rising per capita healthcare expenditure in this region.
Key market players that are engaged in in vitro diagnostics market are (in alphabetical order) Abbott, Agilent Technologies, bioMérieux, Bio-Rad Laboratories, Charles River Laboratories, Qiagen, Quest Diagnostics, Quidel, Siemens Healthineers and Sysmex. This market report includes an easily searchable excel database of all the In Vitro diagnostics companies worldwide.
Key Geographical Regions
Key Market Players
There has been recent activity in the In Vitro diagnostics industry and some of the key developments have been mentioned below: